ジーエヌアイグループの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/04 | 2,133 | 2,196 | 2,128 | 2,170 | +30 | +1.4% | 747,300 |
2021/06/03 | 2,094 | 2,150 | 2,076 | 2,140 | +50 | +2.4% | 829,500 |
2021/06/02 | 2,121 | 2,147 | 2,077 | 2,090 | -31 | -1.5% | 719,700 |
2021/06/01 | 2,113 | 2,130 | 2,073 | 2,121 | -3 | -0.1% | 595,400 |
2021/05/31 | 2,071 | 2,133 | 2,049 | 2,124 | +61 | +3% | 795,300 |
2021/05/28 | 2,024 | 2,070 | 2,015 | 2,063 | +56 | +2.8% | 755,400 |
2021/05/27 | 2,000 | 2,021 | 1,972 | 2,007 | +3 | +0.1% | 779,100 |
2021/05/26 | 1,976 | 2,018 | 1,955 | 2,004 | +18 | +0.9% | 692,500 |
2021/05/25 | 1,957 | 2,006 | 1,941 | 1,986 | +29 | +1.5% | 880,000 |
2021/05/24 | 2,004 | 2,016 | 1,937 | 1,957 | -49 | -2.4% | 1,063,700 |
2021/05/21 | 2,009 | 2,042 | 1,957 | 2,006 | +13 | +0.7% | 2,189,700 |
2021/05/20 | 2,195 | 2,215 | 1,988 | 1,993 | -337 | -14.5% | 7,473,900 |
2021/05/19 | 2,153 | 2,334 | 2,130 | 2,330 | +181 | +8.4% | 4,641,600 |
2021/05/18 | 1,958 | 2,178 | 1,950 | 2,149 | +325 | +17.8% | 7,168,600 |
2021/05/17 | 1,915 | 1,930 | 1,811 | 1,824 | -111 | -5.7% | 1,004,300 |
2021/05/14 | 1,854 | 2,021 | 1,831 | 1,935 | +94 | +5.1% | 1,313,600 |
2021/05/13 | 1,846 | 1,891 | 1,793 | 1,841 | -23 | -1.2% | 971,100 |
2021/05/12 | 2,003 | 2,022 | 1,812 | 1,864 | -144 | -7.2% | 2,109,900 |
2021/05/11 | 1,985 | 2,024 | 1,983 | 2,008 | +8 | +0.4% | 608,400 |
2021/05/10 | 2,033 | 2,037 | 2,000 | 2,000 | ±0 | ±0% | 236,000 |
2021/05/07 | 1,986 | 2,044 | 1,960 | 2,000 | ±0 | ±0% | 492,800 |
2021/05/06 | 2,043 | 2,052 | 1,995 | 2,000 | -41 | -2% | 486,500 |
2021/04/30 | 2,026 | 2,041 | 2,006 | 2,041 | +11 | +0.5% | 262,600 |
2021/04/28 | 2,087 | 2,096 | 2,020 | 2,030 | -57 | -2.7% | 475,500 |
2021/04/27 | 2,060 | 2,121 | 2,050 | 2,087 | +45 | +2.2% | 611,500 |
2021/04/26 | 2,020 | 2,044 | 1,991 | 2,042 | +19 | +0.9% | 383,600 |
2021/04/23 | 2,026 | 2,089 | 2,017 | 2,023 | -1 | ±0% | 627,900 |
2021/04/22 | 2,012 | 2,038 | 2,003 | 2,024 | +40 | +2% | 421,700 |
2021/04/21 | 1,990 | 2,010 | 1,965 | 1,984 | -28 | -1.4% | 729,100 |
2021/04/20 | 1,998 | 2,026 | 1,986 | 2,012 | +7 | +0.3% | 400,000 |
2021/04/19 | 2,050 | 2,054 | 1,999 | 2,005 | -45 | -2.2% | 470,900 |
2021/04/16 | 2,030 | 2,077 | 2,030 | 2,050 | +20 | +1% | 457,100 |
2021/04/15 | 1,990 | 2,036 | 1,973 | 2,030 | +10 | +0.5% | 449,800 |
2021/04/14 | 2,011 | 2,033 | 1,983 | 2,020 | +11 | +0.5% | 529,400 |
2021/04/13 | 2,018 | 2,056 | 1,998 | 2,009 | -21 | -1% | 549,300 |
2021/04/12 | 2,122 | 2,122 | 2,028 | 2,030 | -96 | -4.5% | 768,400 |
2021/04/09 | 2,104 | 2,146 | 2,104 | 2,126 | +22 | +1% | 463,500 |
2021/04/08 | 2,118 | 2,120 | 2,054 | 2,104 | -32 | -1.5% | 664,100 |
2021/04/07 | 2,173 | 2,187 | 2,117 | 2,136 | -39 | -1.8% | 650,100 |
2021/04/06 | 2,133 | 2,175 | 2,133 | 2,175 | +45 | +2.1% | 520,500 |
2021/04/05 | 2,115 | 2,162 | 2,092 | 2,130 | -1 | ±0% | 652,500 |
2021/04/02 | 2,209 | 2,218 | 2,120 | 2,131 | -74 | -3.4% | 869,300 |
2021/04/01 | 2,218 | 2,246 | 2,183 | 2,205 | +32 | +1.5% | 571,500 |
2021/03/31 | 2,187 | 2,222 | 2,152 | 2,173 | -9 | -0.4% | 568,700 |
2021/03/30 | 2,230 | 2,268 | 2,146 | 2,182 | -45 | -2% | 1,047,800 |
2021/03/29 | 2,335 | 2,345 | 2,195 | 2,227 | -121 | -5.2% | 1,253,800 |
2021/03/26 | 2,280 | 2,362 | 2,275 | 2,348 | +42 | +1.8% | 902,700 |
2021/03/25 | 2,380 | 2,400 | 2,222 | 2,306 | -68 | -2.9% | 1,763,400 |
2021/03/24 | 2,498 | 2,525 | 2,370 | 2,374 | -157 | -6.2% | 1,914,800 |
2021/03/23 | 2,436 | 2,564 | 2,418 | 2,531 | +102 | +4.2% | 1,940,300 |
951~
1000
件表示中 / 3685件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ジーエヌアイ | 219,000円 | +21.7% | +999.9% | 0.00% | 9.12倍 | 3.02倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 233,400円 | +14.2% | +41.0% | 1.97% | 11.43倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
持田薬 | 307,500円 | +3.0% | +27.5% | 2.60% | 19.47倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 222,400円 | +0.4% | -8.4% | 2.38% | 28.55倍 | 1.61倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム